The role of KL-6 use has already been confirmed in other lung diseases, such as pulmonary fibrosis, interstitial lung disease, idiopathic pulmonary fibrosis, diffuse parenchymal lung disease, and many others [43,44]. Here, MUC1 is linked to pulmonary fibrosis.